Search results
Results from the WOW.Com Content Network
Glycogenesis is the process of glycogen synthesis or the process of converting glucose into glycogen in which glucose molecules are added to chains of glycogen for storage. This process is activated during rest periods following the Cori cycle , in the liver , and also activated by insulin in response to high glucose levels .
Glycogenolysis is the breakdown of glycogen (n) to glucose-1-phosphate and glycogen (n-1). Glycogen branches are catabolized by the sequential removal of glucose monomers via phosphorolysis , by the enzyme glycogen phosphorylase .
Conversely, glycogenesis is enhanced and glycogenolysis inhibited when there are high levels of insulin in the blood. [ 15 ] The level of circulatory glucose (known informally as "blood sugar"), as well as the detection of nutrients in the Duodenum is the most important factor determining the amount of glucagon or insulin produced.
α(1→4)-glycosidic linkages in the glycogen oligomer α(1→4)-glycosidic and α(1→6)-glycosidic linkages in the glycogen oligomer. Glycogen is a branched biopolymer consisting of linear chains of glucose residues with an average chain length of approximately 8–12 glucose units and 2,000-60,000 residues per one molecule of glycogen.
Glycogenesis is the metabolic pathway in which glycogen is created. Glycogen, which consists of branched long chains made out of the simple sugar glucose , is an energy storage form for carbohydrates in many human cells; this is most important in liver , muscle and certain brain cells .
Glycogen synthase (UDP-glucose-glycogen glucosyltransferase) is a key enzyme in glycogenesis, the conversion of glucose into glycogen. It is a glycosyltransferase (EC 2.4.1.11) that catalyses the reaction of UDP-glucose and (1,4-α-D-glucosyl) n to yield UDP and (1,4-α-D-glucosyl) n+1.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
As it affects glycogenolysis, it has been suggested that it should re-designated as GSD-XIV. [3] Lafora disease is considered a complex neurodegenerative disease and also a glycogen metabolism disorder. [40] Polyglucosan storage myopathies are associated with defective glycogen metabolism [41]